We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.69%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$90B
AUM Growth
-$2.64B
(-2.9%)
Cap. Flow
+$2.07B
Cap. Flow
% of AUM
2.3%
Top 10 Holdings %
Top 10 Hldgs %
17.41%
Holding
2,101
New
60
Increased
1,058
Reduced
623
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$327M |
| 2 |
Broadcom
AVGO
|
+$315M |
| 3 |
Mastercard
MA
|
+$262M |
| 4 |
Intuit
INTU
|
+$226M |
| 5 |
Digital Realty Trust
DLR
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$169M |
| 3 |
WCN
Waste Connections
WCN
|
+$141M |
| 4 |
NextEra Energy
NEE
|
+$134M |
| 5 |
Cadence Design Systems
CDNS
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.36% |
| 2 | Industrials | 16.63% |
| 3 | Healthcare | 13.3% |
| 4 | Financials | 8.12% |
| 5 | Consumer Discretionary | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Avantor
AVTR
$9.31B
| $83.5M | 0.09% |
5,153,812
-1,406,980
| -21% | -$26.7M |
|
227
International Paper
IP
$22.1B
| $82.7M | 0.09% |
1,551,000
+268,310
| +21% | +$14.7M |
|
228
Packaging Corp of America
PKG
$22.9B
| $82.7M | 0.09% |
417,649
-58,488
| -12% | -$12.5M |
|
229
Deckers Outdoor
DECK
$12.8B
| $82.5M | 0.09% |
738,222
+23,170
| +3% | +$3.74M |
|
230
Ralph Lauren
RL
$23.7B
| $81.5M | 0.09% |
369,124
+22,233
| +6% | +$5.51M |
|
231
West Fraser Timber
WFG
$5.6B
| $81.2M | 0.09% |
1,057,204
-1,271
| -0.1% | -$105K |
|
|
SCHW
232
Charles Schwab
SCHW
$186B
| $81M | 0.09% |
1,034,454
+47,244
| +5% | +$3.71M |
|
233
Nextpower Inc
NXT
$15.9B
| $80.5M | 0.09% |
1,910,429
+687,810
| +56% | +$30.6M |
|
234
ICICI Bank
IBN
$107B
| $79.2M | 0.09% |
2,514,067
+2,090,071
| +493% | +$60.6M |
|
235
Allegion
ALLE
$14.3B
| $79.2M | 0.09% |
607,518
-704,593
| -54% | -$91.2M |
|
236
Cytokinetics
CYTK
$10.6B
| $78.9M | 0.09% |
1,956,327
+44,328
| +2% | +$2.04M |
|
237
Equity Residential
EQR
$24.4B
| $77.2M | 0.09% |
1,079,151
-15,072
| -1% | -$1.06M |
|
238
Datadog
DDOG
$88.6B
| $76M | 0.08% |
766,517
+2,793
| +0.4% | +$352K |
|
239
Pfizer
PFE
$152B
| $75.3M | 0.08% |
2,972,530
+475,423
| +19% | +$12.4M |
|
240
Albemarle
ALB
$15.3B
| $74.3M | 0.08% |
1,030,996
-161,531
| -14% | -$13.1M |
|
241
Kimberly-Clark
KMB
$36.1B
| $74.1M | 0.08% |
520,822
-28,901
| -5% | -$3.89M |
|
|
SWTX
242
DELISTED
SpringWorks Therapeutics
SWTX
| $73.7M | 0.08% |
1,670,008
-721,404
| -30% | -$33.2M |
|
243
CoStar Group
CSGP
$12.6B
| $73.6M | 0.08% |
929,105
-105,047
| -10% | -$7.99M |
|
244
Incyte
INCY
$24.5B
| $73.3M | 0.08% |
1,209,609
-104,264
| -8% | -$7.27M |
|
245
BridgeBio Pharma
BBIO
$16.4B
| $72.4M | 0.08% |
2,090,268
+282,796
| +16% | +$9.54M |
|
246
Extra Space Storage
EXR
$31B
| $71.4M | 0.08% |
481,148
-19,145
| -4% | -$2.9M |
|
247
RTX Corp
RTX
$302B
| $71.4M | 0.08% |
538,709
-13,522
| -2% | -$1.71M |
|
248
DoorDash
DASH
$91.9B
| $71.1M | 0.08% |
389,132
+217,070
| +126% | +$40.8M |
|
249
Cigna
CI
$72.4B
| $70.7M | 0.08% |
214,774
-119,912
| -36% | -$36.1M |
|
250
Planet Fitness
PLNT
$3.62B
| $70.2M | 0.08% |
726,550
+19,191
| +3% | +$1.93M |
|
Similar funds
Pictet Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Pictet Asset Management held 2,101 positions worth $90B, down 2.9% from $92.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Pictet Asset Management's Q1 2025 filing shows 60 new, 1,058 increased, 623 reduced and 92 closed positions. Its largest new stake was Verona Pharma: 703,063 shares worth $44.6M. The largest sale was Intra-Cellular Therapies Inc., an estimated $187M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Industrials and Healthcare.
- Pictet Asset Management's largest Q1 2025 buy was Verona Pharma: 703,063 shares worth $44.6M.
- Pictet Asset Management added most to Synopsys in Q1 2025, an estimated $327M increase.
- Pictet Asset Management's biggest Q1 2025 reduction was Intra-Cellular Therapies Inc., cutting an estimated $187M.
- Pictet Asset Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2025, selling an estimated $46.5M.
- Pictet Asset Management's ten largest holdings make up 17% of its $90B portfolio in Q1 2025.
- Pictet Asset Management opened 60 new positions and closed 92 in Q1 2025.
- Pictet Asset Management's portfolio value fell 2.9% quarter-over-quarter to $90B.
Based on Pictet Asset Management's 13F filing for Q1 2025, filed 5 May 2025.